Hematologic side effects of PEG interferon and ribavirin: Management with growth factors

Journal of Clinical Gastroenterology

Volumn 39, Issue 1 SUPPL., 2005, Pages

  Keeffe, Emmet B ^a   Kowdley, Kris V ^b,c  

^a STANFORD UNIVERSITY MEDICAL CENTER   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; GRANULOCYTE COLONY STIMULATING FACTOR; GROWTH FACTOR; HEMOGLOBIN; INTERFERON; NOVEL ERYTHROPOIESIS STIMULATING PROTEIN; PEGINTERFERON; RECOMBINANT ERYTHROPOIETIN; RIBAVIRIN;

ANEMIA; BLOOD TOXICITY; BONE MARROW SUPPRESSION; DRUG DOSE REDUCTION; EDITORIAL; GENOTYPE; HEMOLYTIC ANEMIA; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; INCIDENCE; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; NEUTROPENIA; PATIENT COMPLIANCE; PRIORITY JOURNAL; SIDE EFFECT; THROMBOCYTOPENIA;

EID: 11144278677     PISSN: 01920790     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.mcg.0000145495.83928.0d     Document Type: Editorial

References (0)